Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Case | CASE | Nov 21, 2024 | 16.50 | +6.45 |
Castellum | CAST | Nov 21, 2024 | 122.15 | -0.04 |
Catella A | CATA | Nov 21, 2024 | 30.20 | +7.86 |
Catella B | CATB | Nov 21, 2024 | 28.15 | 0.00 |
Catena | CATE | Nov 21, 2024 | 474.00 | -0.73 |
Catena Media | CTM | Nov 21, 2024 | 4.44 | +7.12 |
Cavendish Hydrogen | CAVENO | Nov 21, 2024 | 9.95 | -3.40 |
Cavotec SA | CCC | Nov 21, 2024 | 16.65 | -2.06 |
CDON | CDON | Nov 21, 2024 | 94.00 | 0.00 |
Cedergrenska | CEDER | Nov 21, 2024 | 27.60 | -2.82 |
Cell Impact | CI | Nov 21, 2024 | 0.17 | -2.23 |
CellaVision | CEVI | Nov 21, 2024 | 214.50 | +1.42 |
Cereno Scientific B | CRNOB | Nov 21, 2024 | 4.90 | -1.05 |
ChargePanel AB (publ) | CHARGE | Nov 21, 2024 | 1.49 | +2.76 |
Checkin.com Group | CHECK | Nov 21, 2024 | 17.10 | -5.00 |
Cheffelo | CHEF | Nov 21, 2024 | 24.80 | +0.40 |
Chordate Medical Holding | CMH | Nov 21, 2024 | 20.80 | -0.48 |
Chosa Oncology AB | CHOSA | Nov 21, 2024 | 0.80 | +33.33 |
ChromoGenics | CHRO | Nov 21, 2024 | 9.78 | 0.00 |
Cibus Nordic Real Estate | CIBUS | Nov 21, 2024 | 166.75 | -0.36 |
Cinclus Pharma Holding AB | CINPHA | Nov 21, 2024 | 19.66 | -2.43 |
Cinis Fertilizer AB | CINIS | Nov 21, 2024 | 14.34 | -6.27 |
Cint Group | CINT | Nov 21, 2024 | 11.63 | +1.66 |
CirChem | CIRCHE | Nov 21, 2024 | 2.94 | -1.67 |
Circle Energy Sweden B | CIRCLEB | Nov 21, 2024 | 0.00 | 0.00 |
Clas Ohlson B | CLASB | Nov 21, 2024 | 187.50 | +1.41 |
Clavister Holding | CLAV | Nov 21, 2024 | 1.83 | +3.11 |
Clean Motion | CLEMO | Nov 21, 2024 | 0.36 | -1.11 |
Clemondo Group | CLEM | Nov 21, 2024 | 0.77 | -2.30 |
Climeon B | CLIMEB | Nov 21, 2024 | 0.32 | -2.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.